Sudden Visual Loss as an Initial Manifestation of Chronic Myeloid Leukemia

Chronic myelogenous leukemia (CML) is a pluripotent stem cell disease characterized by anemia, granulocytosis and granulocytic immaturity, basophilia, thrombocytosis and splenomegaly. It is associated with a reciprocal chromosomal translocation t (q34; q11), resulting in a breakpoint cluster region-...

Full description

Saved in:
Bibliographic Details
Published inSaudi journal of medicine & medical sciences Vol. 5; no. 3; pp. 278 - 280
Main Authors Buzaid, Ahmed N, Al-Amri, Ali M
Format Journal Article
LanguageEnglish
Published India Medknow Publications and Media Pvt. Ltd 01.09.2017
Medknow Publications & Media Pvt Ltd
Wolters Kluwer Medknow Publications
Subjects
Blindness
Case Report
Case studies
Chronic myelogenous leukemia
Chronic myeloid leukemia
Diagnosis
retinal hemorrhage
Saudi
visual loss
retinal hemorrhage
Chronic myelogenous leukemia
Saudi
visual loss
Online AccessGet full text

Cover

More Information
Summary:Chronic myelogenous leukemia (CML) is a pluripotent stem cell disease characterized by anemia, granulocytosis and granulocytic immaturity, basophilia, thrombocytosis and splenomegaly. It is associated with a reciprocal chromosomal translocation t (q34; q11), resulting in a breakpoint cluster region-Abelson fusion gene (Philadelphia chromosome). Ophthalmic manifestations as the first and the only presentation of CML in patients are very rare. Ocular lesions in CML patients are frequently asymptomatic, and thus all patients should undergo an eye evaluation at the initial diagnosis. Here, we report a previously healthy 36-year-old Saudi male who initially presented with progressive loss of vision. On examination, he was found to have a bilateral retinal hemorrhage. The investigations revealed findings consistent with CML. The patient was treated with tyrosine kinase inhibitors, and he had complete remission, including full recovery of his vision.
ISSN:1658-631X
2321-4856
DOI:10.4103/sjmms.sjmms_35_16